Compound Detail
CHEMBL152649
CHLORMIDAZOLE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL152649 |
| Name | CHLORMIDAZOLE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | WNAQOLSMVPFGTE-UHFFFAOYSA-N |
4
Targets
8
Activities
1
Assay Types
0
PK Parameters
10
Publications
2
Known Names
Molecular Properties
256.7
MW (Da)
4.05
ALogP
2
HBA
0
HBD
17.8
PSA (Ų)
0.68
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
ATC Classification
D01AC04
chlormidazole
Level 1: DERMATOLOGICALS
Level 2: ANTIFUNGALS FOR DERMATOLOGICAL USE
Activity Summary
IC50 8 meas. best 7.5
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 7.5 | 5.726 | 31.8 | 5 |
| Galanin receptor type 3 CHEMBL2731 | IC50 | 6.69 | 6.69 | 203.2 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.72 | 5.72 | 1890.0 | 1 |
| COUP transcription factor 2 CHEMBL1961790 | IC50 | 4.97 | 4.97 | 10603.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.1016/S0960-894X(97)00046-2 | Adrenergic receptor beta | 1 |
| - | 10.1101/2020.04.03.023846 | SARS-CoV-2 | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | Caco-2 | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | ADMET | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine